FDA NDC Directory · JSON-LD · Markdown

Lumizyme

NDC 58468-0160 · HUMAN PRESCRIPTION DRUG · INJECTION, POWDER, FOR SOLUTION

Generic nameALGLUCOSIDASE ALFA
Labeler / ManufacturerGenzyme Corporation
Marketing categoryBiologic License Application · App BLA125291
Dosage form / routeINJECTION, POWDER, FOR SOLUTION · INTRAVENOUS
Active ingredientsALGLUCOSIDASE ALFA (5 mg/mL)
Marketing started20100524
Package count1

External sources

Source: openFDA. Public-domain (CC0).